Balance Sheet Components - Summary of Accrued Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Accrued Liabilities, Current [Abstract] | ||
| Accrued research and development-related expenses | $ 1,393 | $ 1,650 |
| Accrued clinical trial-related expenses | 149 | 268 |
| Accrued professional services expenses | 101 | 84 |
| Accrued offering costs | 82 | 0 |
| Other | 22 | 50 |
| Total accrued liabilities | $ 1,747 | $ 2,052 |
| X | ||||||||||
- Definition Accrued Clinical Trial Related Expenses Current No definition available.
|
| X | ||||||||||
- Definition Accrued offering costs current. No definition available.
|
| X | ||||||||||
- Definition Accrued professional services expenses No definition available.
|
| X | ||||||||||
- Definition Accrued research and development-related expenses current. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|